CANCER E-STAGING STANDALONE PROGRAM
Dr Sanjoy SanyalMBBS, MS, MSc (RCSEd), ADPHA
Professor and Course [email protected]
Patent Pending
http://www.slideshare.net/sanyalsanjoy8/cancer-e-staging-standalone-program
Abstract• Given the extreme complexity of grouping T, N, M
status of a tumor into its Stages, it is impossible to determine the Anatomical Stage of any cancer without the aid of complex TNM charts created by UICC.
• In order to render the process time- and user-friendly for the physician, an MS™ Excel-based e-Staging program was created for 26 cancers of human body.
• With just 5 mouse clicks one can arrive at the Stage of the cancer.
• This is a standalone tool, not requiring Internet connection, and can be used in a handheld device in any hospital or clinic.
Background
• In the Union for International Cancer Control
(UICC) TNM classification, Tumor status (T) is
designated as T1, T2 etc, lymph Node
metastases (N) are designated as N0, N1 etc,
and distant Metastases (M) are designated as
M0, M1.
• For some cancers, like Seminoma of testis, Serum tumor marker (S) is an additional parameter.
Background
• Each parameter may be further subdivided
into 'a', 'b' etc.
• The three (or four) major parameters are
grouped in increasing stages of cancer to give
the Anatomical Stage of the cancer,
designated by Roman numeral I, II etc.
• For many cancer, Stages may be subdivided
into 'A', 'B'.
Process Flowchart for Creation of Cancer e-Staging Standalone Program
A multi-step process was used to create the e-Staging Program.
Process Flowchart for Implementation of Cancer e-Staging Standalone Program
Cancer e-Staging Standalone Program
• It has 6 electronic pages, requiring 5 mouse clicks
• Content page of the e-Staging tool gives a list of 26
cancers. It comes once we click on the Agree Tab
• Once on any Tumor page, the physician is asked to
successively select the appropriate T, N, M status of
that cancer.
• It takes the physician seamlessly through the 3
steps.
• Final page gives cancer Stage.
Terms of Use Agreement
Content Page of e-Staging Program
Second Mouse Click: Click on the cancer of choice, for which Staging is required
Tumor (T) Page of e-Staging Program
Third Mouse Click: Click on the Tumor status (T) of the cancer for which Staging is required
Node (N) Page of e-Staging Program
Fourth Mouse Click: Click on the Lymph Node status (N) of the cancer for which Staging is required
Metastases (M) Page of e-Staging Program
Fifth Mouse Click: Click on the Metastasis status (M) of the cancer for which Staging is required
Staging Page of e-Staging Program
Final Page: Gives the Anatomical Stage of the cancer for which Staging is required
Uniqueness of e-Staging Program• This interactive e-Staging tool is standalone,
simpler (requiring only 5 mouse clicks),
quicker (just a few seconds) and easier than
those from others that are all Web-based.
• It can be used by any physician with minimum
computer skills.
• It is portable, can be used in any hand-held
device anywhere in the hospital or clinic, and
does not require Internet connection.
Uniqueness of e-Staging Program• It eliminates consulting complicated TNM
charts, which are different for every tumor,
and also the need to rely on memory, thus
reducing errors and inconsistency between
physicians.
• The tool can be incorporated in a hospital
EMR with HL7.
• It is future-scalable, with options to add
more cancer sites to the system.
Authorship and Conference Presentation• This paper and program was authored by Dr Sanjoy
Sanyal, Professor and Course Director of
Neuroscience in Medical University of the Americas, Nevis, St Kitts-Nevis, West Indies.
• It was accepted at the international Stanford
Medicine X Conference, and presented as a poster in Stanford University School of Medicine, LKSC Conference Center, 291 Campus Drive, Stanford, CA
94305-5101, USA, on 30 September, 2012. • Assistance of Medical University of the Americas in
preparing the poster is gratefully acknowledged.
Stanford Medicine X Conference 2012
Stanford Medicine X Conference 2012
Stanford Medicine X Conference 2012
PATENT STATUS
Provisional Patent Application accepted by United States Patent and Trademark Office (USPTO) in January 2014, giving it a 'Patent Pending' status.
